- Home
- MX vs LENZ Comparison
MX vs LENZ Comparison
Compare MX & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MX | LENZ |
|---|---|---|
| Founded | 2003 | 2019 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.2M | 219.8M |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MX | LENZ |
|---|---|---|
| Price | $6.99 | $7.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $5.75 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 4.0M | 777.5K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.06 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $178,860,000.00 | $19,088,000.00 |
| Revenue This Year | $8.55 | $50.42 |
| Revenue Next Year | $6.37 | $197.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.18 | $6.61 |
| 52 Week High | $9.86 | $50.19 |
Technical Indicators
Market Signals| Indicator | MX | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 56.16 | 37.13 |
| Support Level | $2.66 | $6.61 |
| Resistance Level | N/A | $10.42 |
| Average True Range (ATR) | 1.15 | 0.49 |
| MACD | 0.18 | 0.02 |
| Stochastic Oscillator | 50.25 | 20.74 |
Price Performance
Historical ComparisonAbout MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The Company operates within a single operating segment, Power Solutions business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.